These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2147620)

  • 21. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
    Liedholm H; Ursing D
    Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol.
    Jeck T; Edmonds D; Mengden T; Schubert M; Renz I; Weisser B; Vetter W
    Int J Clin Pharmacol Res; 1992; 12(3):139-48. PubMed ID: 1473881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinico-therapeutic experience with a new antihypertensive drug, ketanserin, in elderly patients].
    Neri G; Iovine C
    Clin Ter; 1989 Sep; 130(5):245-8. PubMed ID: 2530025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group.
    Baird MG; Bentley-Taylor MM; Carruthers SG; Dawson KG; Laplante LE; Larochelle P; MacCannell KL; Marquez-Julio A; Silverberg LR; Talbot P
    Clin Invest Med; 1984; 7(2):95-102. PubMed ID: 6380858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR; Amstein R
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metoprolol for hypertension. Open trial in general practice.
    Fredman RM
    Med J Aust; 1982 Oct; 2(8):378-80. PubMed ID: 6755204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
    Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cross-over study on the effects of ketanserin vs enalapril in the treatment of hypertension].
    Modica G; Monte I; Guerini Rocco C
    Minerva Cardioangiol; 1995 Apr; 43(4):145-53. PubMed ID: 7644088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
    Leary WP; Reyes AJ; van der Byl K; Maharaj B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy of the combination of ketanserin + thiazide in hypertensives older than 50 years.
    Ferrara LA; Fasano ML; Soro S; Pasanisi F; Mancini M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S124-6. PubMed ID: 2446060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related effects of 5-HT2 antagonists.
    Doyle AE
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S29-34. PubMed ID: 1717770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketanserin in the treatment of essential hypertension. A double blind trial against metoprolol followed by one-year open treatment.
    Milei J; Lemus J; Finkielman S; Nahmod VE; Bernardiner E
    Clin Exp Hypertens A; 1989; 11(3):371-89. PubMed ID: 2663239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.